Senior Director, Corporate and Business Development
Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to breaking through barriers in gene therapy and neurology. The potential of both disciplines has been constrained by delivery challenges; Voyager is leveraging cutting-edge expertise in capsid discovery and deep neuropharmacology capabilities to address these constraints. Voyager’s TRACER™ AAV capsid discovery platform has generated novel capsids with high target delivery and blood-brain barrier penetration at low doses, potentially addressing the narrow therapeutic window associated with conventional gene therapy delivery vectors. This platform is fueling alliances with Pfizer Inc., Novartis Pharma AG, Neurocrine Biosciences, Inc., and Sangamo Therapeutics, Inc., as well as multiple programs in Voyager’s own pipeline. Voyager’s pipeline includes wholly owned and collaborative preclinical programs in Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and other diseases of the central nervous system, with a focus on validated targets and biomarkers to enable a path to rapid potential proof-of-biology. For more information, visit www.voyagertherapeutics.com.
Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.
Voyager Therapeutics is growing and is adding a Senior Director, to our Corporate & Business Development team. The Senior Director, Corporate and Business Development will contribute to partnering and collaboration efforts by identifying and evaluating new business opportunities, including partnerships, collaborations, and licenses relating to Voyager’s platform and programs and the acquisition of new assets and technologies. This individual will also be involved in strategic planning and analyses, which will involve gathering competitive intelligence and developing financial models. This role will build and maintain strong relationships within the team, cross-functionally, and externally. The ideal candidate has extensive experience in digesting scientific and technical information to translate into business analyses. Substantial relevant industry experience is required and an advanced degree in a relevant scientific discipline (e.g., neuroscience, molecular biology, genetics) or highly relevant, direct experience in genetic medicine or neuroscience is preferred. An MBA and/or management consulting experience are highly desirable. This role This position is a critical function within this core team and will report to the Chief Business Officer.
Position Specific Responsibilities:
- Develop a partnering strategy that supports Voyager’s Research and Development teams and accordingly identify, evaluate, propose, and present new business opportunities and assist in related transactions, including running diligence and supporting negotiations, working in collaboration with team and cross-functionally with R&D, Finance, Legal, Program Management, and other departments as well as with outside counsel and consultants.
- Contribute to strategic planning initiatives in collaboration with the Corporate & Business Development team, Finance, R&D, and Technical Operations.
- Forge strong relationships and work closely with internal stakeholders to understand and support objectives and their translation into corporate and business development opportunities. Acts as a thought partner to R&D and G&A functions to ensure the corporate strategy is aligned and supported. This role challenges the Leadership Teams to think innovatively when it comes to partnering with external innovators, academics, biotechnology, or established pharmaceutical companies.
- Performs complex analyses of a range of opportunities with significant financial investment in accordance with growth and profitability objectives
- Negotiates on behalf of Voyager in support of in-licensing, out-licensing, co-promotions, M&A, etc.
- Build strong relationships and networks with potential external partners.
- Continuously monitor developments in the field via published literature, trade press, conferences, and relationships across academia and industry, to stay current to effectively share late-breaking developments and industry trends with key internal stakeholders.
- Contribute to the development and evolution of corporate and business development strategies and objectives.
- Fosters and contributes to a vibrant team and company culture.
Experience and Skills Desired
- Minimum >10+years of experience in corporate and business development portfolio strategy, and/or closely related disciplines in the biotechnology or pharmaceuticals industry (with credit for scientific experience but substantial post-scientific experience required). Substantive exposure to genetic medicines and/or neurologic disease preferred.
- Bachelor’s degree required (with major in the biological sciences preferred); graduate degree required, MA, MS, MBA, JD, PhD, and/or MD. Specific experience in genetic medicine and/or neurological disease preferred.
- Deal and negotiation experience with track record of leading or substantially contributing to transactions (e.g., partnership, collaboration, license, M&A, research agreements), Deal Sheet demonstrating significant closed transactions is a requirement.
- Passion for Voyager’s mission to advance life-changing gene therapies and other therapeutic modalities for neurological diseases.
- Facility for and comfort with working both proactively and collaboratively and within and across functions.
- Strong business acumen and financial literacy.
- Experience leading teams and proactively managing cross-functional groups, including members of senior leadership. Ability to “drive” complex processes and transactions internally and externally, experience leading cross-functional projects. Must demonstrate gravitas to help drive internal BD strategy within the organization and hold/drive meaningful discussions externally with Pharma/Biotech executives and key opinion leaders.
- Understanding of drug development and regulatory requirements as they relate to business development activities.
- Knowledge of competitive landscape and industry players preferred. Deep understanding of the drug development, approval, and commercialization processes. Ability to efficiently ascend the learning curve required.
- Creativity, innovative thinking, and open-mindedness with exceptional communication and interpersonal skills.
- Demonstrated ability to apply strategic and critical-thinking skills.
- Openness and willingness to learn from all colleagues, regardless of level or hierarchy.
- Analytical approach, strong critical thinking and decision-making skills.
- Creative, results oriented self-starter with the ability to deliver high quality deliverables on time that are appropriate for review by senior management.
- Thrives in dynamic, intellectually stimulating environment.